Press releases
Read press releases issued by GlaxoSmithKline Pharmaceuticals Limited.
Our Global press releases can be viewed on our global website.
-
GlaxoSmithKline Pharmaceuticals Limited delivers strong financials led by Pharma growth
GlaxoSmithKline Pharmaceuticals Ltd today declared its financial results for the quarter ended December 31, 2021
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended September 30, 2021
GlaxoSmithKline Pharmaceuticals Ltd today declared its financial results for the quarter ended September 30, 2021
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended June 30, 2021
GlaxoSrnithircline Pharmaceuticals Limited today declared its financial results for the quarter ended June 30, 2021
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter and full year ended March 31, 2021
GlaxoSmithKline Pharmaceuticals Limited today declared its financial results for the quarter ended 31st March 2021
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended December 31, 2020
GlaxoSmithKline Pharmaceuticals Limited today declared its f inancial results for the quarter ended 31 st December 2020
-
GSK, PATH and Bharat Biotech sign product transfer agreement to help ensure long-term supply of ground-breaking malaria vaccine
GSK, PATH, and Bharat Biotech (BBIL) today announced the signing of a product transfer agreement for the malaria vaccine
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended September 30, 2020
GlaxoSmithKline Pharmaceuticals Limited today declared its financial results for the quarter ended 30th September 2020
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter ended June 30, 2020
GlaxoSmithKline Pharmaceuticals Limited today declared its financial results f or the quarter ended 30th June 2020
-
GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021
-
GlaxoSmithKline Pharmaceuticals Limited announces results for the quarter and full year ended March 31, 2020
GlaxoSmithKline Pharmaceuticals Limited today declared its financial results for the quarter ended 31st March 2020
-
Appointments to the GlaxoSmithKline Pharmaceuticals Ltd Board
Mr. Deepak Parekh will step down as Non-Executive Director & Chairman of the Board of the Company due to his...
